Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury.
about
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?Cell-based therapy for traumatic brain injuryTransplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats.Neurorestorative therapy for strokeComparative proteomics of human embryonic stem cells and embryonal carcinoma cells.Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?From cell death to neuronal regeneration: building a new brain after traumatic brain injury.Transplantation of human umbilical cord blood cells in the repair of CNS diseases.Transplantation for stroke.Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Neurotrophin-3 gene transduction of mouse neural stem cells promotes proliferation and neuronal differentiation in organotypic hippocampal slice cultures.The future of stem cell therapy for stroke rehabilitationCarbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death.The potential application of gene therapy in the treatment of traumatic brain injury.Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations.Comparative effect of immature neuronal or glial cell transplantation on motor functional recovery following experimental traumatic brain injury in rats.Cell therapy for CNS trauma.Functional assessment of long-term deficits in rodent models of traumatic brain injury.Stem cells for therapy in TBI.Carbon monoxide improves neuronal differentiation and yield by increasing the functioning and number of mitochondria.Novel culture strategy for human stem cell proliferation and neuronal differentiation.Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line-dependent differences.Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury.Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.Differential regulation of GLAST immunoreactivity and activity by protein kinase C: evidence for modification of amino and carboxyl termini.The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency.Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord.
P2860
Q26866149-1838BE10-E300-4E7B-8966-16093035C496Q26998959-1FFC8747-6FDE-4783-85CD-F04439EB299BQ33403038-EC5DC762-99A1-4076-B54D-06DA358B5C06Q33813333-6C9D785C-502A-454D-A2FB-6E73BD25A3E8Q34910536-D493C2CE-8D73-4BFF-8387-45672C96C320Q34982831-9673777F-302F-4F41-8310-C31C16226C2DQ35540623-BD1FA88B-AE2A-43A8-929A-5D75A720EDEDQ35681487-F964B2ED-7475-4B12-AA00-C0111C0F19E6Q35772691-60218946-DCCC-4ADA-A077-90EE7E38107FQ36111849-E9F85905-D00C-40BE-86CE-48C463289D23Q36516349-291C9338-0F9F-4030-928F-D4E46149EE9EQ36697907-F71807DC-0289-4E03-A9FA-F9B8F5BC1F39Q36868551-E4B8F015-0951-4DD6-A5B5-33C1DFD15AFAQ36905532-70A6F113-E302-452E-A1E5-22C6AA83012DQ37194068-C3C61889-65A8-4C28-BC1C-344653854269Q37204809-D36D4B50-3E67-436A-81AD-498051BEE535Q37426384-F73B16D2-673C-4059-B64E-A2C5966611A9Q38119246-461206DD-1024-42A2-A260-ACB8EF7F1063Q38580609-3813DF8B-9D68-456F-A9A4-F7615C82D2FEQ38774547-412AA8C8-25FE-4FF8-9DD7-387C1E6C2680Q40080578-D402FB18-73B3-4537-9D59-E89BAE35280AQ40163855-63BFE022-E8D7-4409-9E69-CB83B7D5581DQ40289382-8C06717C-CCD0-44B9-8B75-798FA0542FF3Q40333561-CD478B34-18D9-4075-A548-08EBE5CBC32CQ40431597-A030FE08-FE15-4D44-B51E-672F602A846BQ45166144-67017312-C8B2-4ADD-A5C4-664B218E867FQ47555620-23354F3B-0ADD-40A0-BFED-9667D5CB8C3BQ50664828-F47F881C-1151-4AF5-82E6-315F21231B3E
P2860
Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Genetically modified NT2N huma ...... mental traumatic brain injury.
@en
Genetically modified NT2N huma ...... mental traumatic brain injury.
@nl
type
label
Genetically modified NT2N huma ...... mental traumatic brain injury.
@en
Genetically modified NT2N huma ...... mental traumatic brain injury.
@nl
prefLabel
Genetically modified NT2N huma ...... mental traumatic brain injury.
@en
Genetically modified NT2N huma ...... mental traumatic brain injury.
@nl
P2093
P2860
P356
P1476
Genetically modified NT2N huma ...... mental traumatic brain injury.
@en
P2093
Carl T Fulp
Deborah J Watson
Edward B Lee
John H Wolfe
Luca Longhi
Marco A Passini
Nicolas C Royo
Scott Fujimoto
Tracy K McIntosh
Virginia M Y Lee
P2860
P304
P356
10.1093/JNEN/62.4.368
P577
2003-04-01T00:00:00Z